Pilot study of atomoxetine in patients with Parkinson’s disease and dopa-unresponsive Freezing of Gait

BACKGROUND: Freezing of gait (FoG) is a common and debilitating condition in Parkinson’s disease (PD) associated with executive dysfunction. A subtype of FoG does not respond to dopaminergic therapy and may be related to noradrenergic deficiency. This pilot study explores the effects of atomoxetine...

Descripción completa

Detalles Bibliográficos
Autores principales: Revuelta, Gonzalo J., Embry, Aaron, Elm, Jordan J., Gregory, Chris, Delambo, Amy, Kautz, Steve, Hinson, Vanessa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676139/
https://www.ncbi.nlm.nih.gov/pubmed/26693006
http://dx.doi.org/10.1186/s40035-015-0047-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676139/
https://www.ncbi.nlm.nih.gov/pubmed/26693006
http://dx.doi.org/10.1186/s40035-015-0047-8

Ejemplares similares